Last updated on April 2018

Effect of Pyridostigmine (Mestinon) on Muscle Strength in Myasthenia Gravis


Brief description of study

A randomized, placebo-controlled, double-blinded cross-over study evaluating and quantifying the effect of pyridostigmine on muscle strength and symptoms in Myasthenia Gravis (MG)

Detailed Study Description

The study aims to evaluate and quantify the effect of pyridostigmine on symptoms and muscle strength in newly-diagnosed patients and patients on stable medication.

Pyridostigmine treatment is initiated in the vast majority of MG patients. No studies have quantified the effect in a randomized trial, and no studies have examined the potential difference in effect in newly diagnosed patients as compared to patients on stable, antimyasthenic medications.

The study will investigate the effect in two groups

  1. Newly diagnosed, treatment-naive patients.
  2. MG patients on stable antimyasthenic medication.

Clinical Study Identifier: NCT03510546

Find a site near you

Start Over